SCHEMBL6676848

SCHEMBL6676848

COC(=O)Oc1cc(N2Cc3cccc(-c4ccc(C(F)(F)F)cc4)c3C2=O)cn1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
UGCG Q16739 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
POLB P06746 6/20 0.36
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ESR1 P03372 1/20 0.36
NR4A1 P22736 1/20 0.36
APEX1 P27695 1/20 0.36
PTPN7 P35236 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6675978 0.91 NPC1 (0.41) TP53NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL7042750 0.85 TP53 (0.43) TP53NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL6677619 0.83 GAA (0.38) TP53NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL6675973 0.82 NPC1 (0.40) TP53NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL7039203 0.75 GAA (0.44) POLB
SCHEMBL22129205 0.65 POLB (0.66) TP53NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL6676838 0.64 BACE1 (0.45) TP53MAPTRAB9ASMN1; SMN2KLRK1
SCHEMBL13570278 0.64 TP53 (0.60) TP53NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL10085768 0.62 TP53 (0.64) TP53NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL22291931 0.62 NPC1 (0.68) TP53NPC1MAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465613-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2004-10-13 EP disclosed
WO-2003057205-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-07-17 WO disclosed
WO-2003004020-A1 HETEROARYL CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-01-16 WO disclosed